|
No records
|
|
41461551400 |
Melva Louisa |
Dr. Melva Louisa, S.Si., M.Biomed. |
Departemen Farmakologi dan Terapeutik |
Ilmu Biomedik (S3) |
The potential of gallic acid as a radiosensitizer on human prostate cancer: A systematic review of preclinical studies |
Cahyono A.T., Louisa M., Mayang Permata T.B., Handoko, Nuryadi E., Kodrat H., Wibowo H., Hariandy Hamid A.R.A., Sekarutami S.M., Gondhowiardjo S.A. |
Malaysian Journal of Medicine and Health Sciences |
|
Q4 |
|
|
|
41461551400 |
Melva Louisa |
Dr. Melva Louisa, S.Si., M.Biomed. |
Departemen Farmakologi dan Terapeutik |
Ilmu Biomedik (S3) |
The effect of human immunodeficiency virus infection on adverse events during treatment of drug-resistant tuberculosis: A systematic review and meta-analysis |
Lazarus G., Tjoa K., Iskandar A.W.B., Louisa M., Sagwa E.L., Padayatchi N., Soetikno V. |
PLoS ONE |
|
Q1 |
|
|
|
41461551400 |
Melva Louisa |
Dr. Melva Louisa, S.Si., M.Biomed. |
Departemen Farmakologi dan Terapeutik |
Ilmu Biomedik (S3) |
Role of TGF-?1 in human breast cancer stem cells |
Hariyanto N.I., Purwandhita R.P., Syahrani R.A., Louisa M., Wanandi S.I. |
Journal of the Pakistan Medical Association |
|
Q4 |
|
|
|
41461551400 |
Melva Louisa |
Dr. Melva Louisa, S.Si., M.Biomed. |
Departemen Farmakologi dan Terapeutik |
Ilmu Biomedik (S3) |
Curcumin Nanoparticle Enhances the Anticancer Effect of Cisplatin by Inhibiting PI3K/AKT and JAK/STAT3 Pathway in Rat Ovarian Carcinoma Induced by DMBA |
Sandhiutami N.M.D., Arozal W., Louisa M., Rahmat D., Wuyung P.E. |
Frontiers in Pharmacology |
3 |
Q1 |
|
|
|
41461551400 |
Melva Louisa |
Dr. Melva Louisa, S.Si., M.Biomed. |
Departemen Farmakologi dan Terapeutik |
Ilmu Biomedik (S3) |
The use of Urinary Lipoarabinomannan (LAM) as a Rapid Diagnostic Test for Adult Pulmonary Tuberculosis in HIV-Positive Patients: An Evidence-based Case Report |
Kusumawardani A., Yanfaunnas A.M., Supandi D.P., Inggita R.A.M., Andayani N.G.A.A.P.T., Louisa M., Soetikno V., Burhan E. |
Journal of International Dental and Medical Research |
|
Q3 |
|
|
|
55650360200 |
Ari Estuningtyas |
Dr. Dra Ari Estuningtyas, Apt., M.Biomed |
Departemen Farmakologi dan Terapeutik |
Pendidikan Dokter (S1) |
Potential inhibition by Phaleria macrocarpa leaves ethanol extract on Ki-67 expression in distal colon mouse |
Kusmardi K., Wiyarta E., Estuningtyas A., Sahar N., Midoen Y.H., Tedjo A., Pakpahan A. |
Pharmacognosy Journal |
|
Q3 |
|
|
|
56039633100 |
Franciscus D.Suyatna |
Prof. dr. Franciscus D.Suyatna, Ph.D., Sp.FK |
Departemen Farmakologi dan Terapeutik |
Ilmu Biomedik (S3) |
Cumulative exposure characteristics of vegetable farmers exposed to Chlorpyrifos in Central Java – Indonesia; a cross-sectional study |
Liem J.F., Mansyur M., Soemarko D.S., Kekalih A., Subekti I., Suyatna F.D., Suryandari D.A., Malik S.G., Pangaribuan B. |
BMC Public Health |
|
Q1 |
|
|
|
56039633100 |
Franciscus D.Suyatna |
Prof. dr. Franciscus D.Suyatna, Ph.D., Sp.FK |
Departemen Farmakologi dan Terapeutik |
Ilmu Biomedik (S3) |
Risk factors predicting intractability in focal epilepsy in children under 3 years of age: A cohort study |
Mangunatmadja I., Ismael S., Sastroasmoro S., Suyatna F.D., van Nieuwenhuizen O., Cornelis van Huffelen A. |
Epilepsy and Behavior |
|
Q2 |
|
|
|
56039633100 |
Franciscus D.Suyatna |
Prof. dr. Franciscus D.Suyatna, Ph.D., Sp.FK |
Departemen Farmakologi dan Terapeutik |
Ilmu Biomedik (S3) |
Cost-effectiveness analysis of genotyping for HLA-B*15:02 in Indonesian patients with epilepsy using a generic model |
Yuliwulandari R., Shin J.G., Kristin E., Suyatna F.D., Prahasto I.D., Prayuni K., Mahasirimongkol S., Cavallari L.H., Mitropoulou C., Patrinos G.P., Hao J., Williams M.S., Snyder S.R. |
Pharmacogenomics Journal |
1 |
Q2 |
|
|
|
56039633100 |
Franciscus D.Suyatna |
Prof. dr. Franciscus D.Suyatna, Ph.D., Sp.FK |
Departemen Farmakologi dan Terapeutik |
Ilmu Biomedik (S3) |
Curcumin's Effect on Inflammatory Response following Percutaneous Coronary Intervention in Adult Patients with Stable Coronary Heart Disease |
Silalahi T., Alwi I., Suyatna F., Sartika K.D. |
International Journal of Angiology |
|
Q3 |
|
|
